stanozolol has been researched along with Leg Dermatoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Browse, NL; Burnand, K; Clemenson, G; Jarrett, PE; Morland, M | 1 |
| Falanga, V; Helfman, T | 1 |
| Browse, NL; Burnand, K; Jarrett, PE; Morland, M | 1 |
1 review(s) available for stanozolol and Leg Dermatoses
| Article | Year |
|---|---|
Stanozolol as a novel therapeutic agent in dermatology.
Topics: Angioedema; Fibrinogens, Abnormal; Humans; Leg Dermatoses; Raynaud Disease; Scleroderma, Localized; Skin Diseases; Stanozolol; Urticaria | 1995 |
1 trial(s) available for stanozolol and Leg Dermatoses
| Article | Year |
|---|---|
Venous lipodermatosclerosis: treatment by fibrinolytic enhancement and elastic compression.
Topics: Adult; Aged; Bandages; Clinical Trials as Topic; Clothing; Double-Blind Method; Female; Humans; Leg Dermatoses; Male; Middle Aged; Scleroderma, Localized; Skin; Stanozolol; Vascular Diseases; Venous Pressure | 1980 |
1 other study(ies) available for stanozolol and Leg Dermatoses
| Article | Year |
|---|---|
Treatment of liposclerosis of the leg by fibrinolytic enhancement: a preliminary report.
Topics: Adult; Female; Humans; Leg Dermatoses; Male; Middle Aged; Sclerosis; Stanozolol; Vascular Diseases | 1977 |